You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 473 Mavrilimumab, a human monoclonal antibody targeting GM-CSFRα, inhibits polarization to myeloid-derived suppressor cells (MDSCs) that express PD-L1 and restores T-cell proliferation in vitro

Article metrics

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Combination immunotherapies
473 Mavrilimumab, a human monoclonal antibody targeting GM-CSFRα, inhibits polarization to myeloid-derived suppressor cells (MDSCs) that express PD-L1 and restores T-cell proliferation in vitro

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020127014
Dec 202015806
Jan 20212507
Feb 20215604
Mar 20215809
Apr 20214603
May 2021707
Jun 2021007
Jul 20210010
Aug 2021007
Sep 2021004
Oct 202126021
Nov 202124013
Dec 20212800
Jan 20225004
Feb 20222206
Mar 20222604
Apr 20225804
May 20224403
Jun 20225407
Jul 20226602
Aug 20224604
Sep 20225802
Oct 20224600
Nov 20224800
Dec 20224801
Jan 20234000
Feb 20233202
Mar 20231202
Apr 20231405
May 20232602
Jun 20231800
Jul 20235205
Aug 2023800
Sep 2023800
Oct 20232802
Nov 20233202
Dec 20233201
Jan 2024800
Feb 20242601
Mar 20242202
Apr 20243401
May 20243000
Jun 20244801
Jul 20241201
Aug 20241204
Sep 20243004
Oct 20241600
Nov 20241600
Dec 20241207
Jan 20252805
Feb 2025401
Apr 2025008
May 2025003
Jun 2025003
Total17210211